Dr. Dr. James Essell
Claim this profileOncology Hematology Care Inc
Studies Diffuse Large B-Cell Lymphoma
Studies Non-Hodgkin's Lymphoma
6 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Dr. James Essell is currently running
Cema-cel
for B-Cell Lymphoma
This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic CD19 CAR T product, as compared to standard of care observation. In this study, participants with MRD are randomized 1:1 to treatment with cema-cel or an observation arm. Treatment includes cema-cel following a lymphodepletion regimen of fludarabine and cyclophosphamide. Prior to August 2025, participants may also have received an anti-CD52 monoclonal antibody, ALLO-647, as part of their lymphodepletion regimen.
Recruiting1 award Phase 25 criteria
CB-011
for Multiple Myeloma
This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation antigen (BCMA), to determine the best dose of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longer responding to other treatment (refractory).
Recruiting1 award Phase 14 criteria
More about Dr. James Essell
Clinical Trial Related13 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dr. James Essell has experience with
- ABL001
- CNTY-101
- Brentuximab Vedotin
- Lisocabtagene Maraleucel
- CB-011
- Cemacabtagene Ansegedleucel
Breakdown of trials Dr. James Essell has run
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Mixed-Cell Lymphoma
Lymphoma
Chronic Illness
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dr. James Essell specialize in?
Dr. James Essell focuses on Diffuse Large B-Cell Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Diffuse Large B-Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Dr. James Essell currently recruiting for clinical trials?
Yes, Dr. James Essell is currently recruiting for 2 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Dr. James Essell has studied deeply?
Yes, Dr. James Essell has studied treatments such as ABL001, CNTY-101, Brentuximab Vedotin.
What is the best way to schedule an appointment with Dr. James Essell?
Apply for one of the trials that Dr. James Essell is conducting.
What is the office address of Dr. James Essell?
The office of Dr. James Essell is located at: Oncology Hematology Care Inc, Cincinnati, Ohio 45242 United States. This is the address for their practice at the Oncology Hematology Care Inc.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.